Related Experiment Video

Updated: Jun 13, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Direct inhibition of eIF4E reduced cell growth in endometrial adenocarcinoma

Chel Hun Choi1, Ji-Soo Lee, Seong Rim Kim

  • 1Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-Gu, Seoul, 135-710, Korea.

Journal of Cancer Research and Clinical Oncology
|May 14, 2010
PubMed
Abstract

Insights

Eukaryotic translation initiation factor 4E (eIF4E) is overexpressed in endometrial cancer and linked to poorer prognosis. Inhibiting eIF4E reduced cancer cell growth, suggesting it as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Eukaryotic translation initiation factor 4E (eIF4E) is frequently overexpressed in various cancers.
  • eIF4E is recognized as a potential therapeutic target in oncology.
  • Limited data exists regarding eIF4E expression in endometrial cancer.

Purpose of the Study:

  • To investigate the expression levels of eIF4E in endometrial cancer specimens.
  • To determine the correlation between eIF4E expression and clinicopathological features, including tumor stage.
  • To assess the therapeutic potential of inhibiting eIF4E in endometrial cancer cell lines.

Main Methods:

  • Immunohistochemistry was employed to analyze eIF4E expression in 62 endometrial cancer surgical samples.
  • The MTT cell proliferation assay was utilized to evaluate cell growth.
  • Small interfering RNA (siRNA) was used to downregulate eIF4E expression in endometrial cancer cell lines.

Main Results:

  • eIF4E expression was found to be positive in 58.1% of the evaluated endometrial cancer specimens.
  • Higher eIF4E positivity significantly correlated with advanced tumor stage (Stage III/IV vs. Stage I/II, P = 0.027).
  • Downregulation of eIF4E using siRNA significantly inhibited the proliferation of HEC-1A cells and, to a lesser extent, Ishikawa cells.

Conclusions:

  • eIF4E expression is associated with the prognosis of endometrial adenocarcinomas.
  • The findings suggest that eIF4E represents a promising therapeutic target for endometrial cancer treatment.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.